benefits of cjc-1295 ipamorelin for anti-aging blend studies cjc-1295 ipamorelin blend benefits studies Peptide Therapy Anti-Aging, Immunity & Wellness cjc-1295 + ipamorelin anti-aging results

The peptide stimulates GH release in a dose-dependent manner while maintaining the natural pulsatile pattern of GH secretion

Gen Pharmacol, 1998

The meta-analysis included 16 studies including patients with asymptomatic hyperuricemia and/or gout treated with febuxostat and were compared with placebo/allopurinol, demonstrating a significant reduction in renal events (doubling of serum creatinine concentration and/or entry into renal replacement therapy): HR 0.56, 95% CI 0.370.84, p = 0.006 and a slight decrease in the fall of glomerular filtration rate (0.90 ml/min/1.73 m2) and in albuminuria.49 Like the observed with allopurinol, there is currently insufficient evidence to suggest treatment with febuxostat for renal or cardiovascular protection in patients with asymptomatic hyperuricemia

2022;19 doi: 10.3390/ijerph19031738

Pparg is thought to be protective against hypertension and was another gene that was downregulated in HK-fed females (53)